Deficiency of phosphomannomutase (PMM) enzyme (PMM2 mutations), catalysing the second step of the N-glycosylation pathway, causes the most frequent CDG, PMM2-CDG (OMIM 212065), with an estimated incidence of 1:20000 [3, 4]. Here, PMM2 is linked to congenital disorder of glycosylation.